Here’s What Makes Haleon (HLN) an Attractive Investment Pick

ClearBridge Investments, an investment management firm, published its “Global Growth Strategy” third-quarter 2022 investor letter – a copy of which can be downloaded here. During the third quarter, the ClearBridge Global Growth Strategy outperformed its MSCI ACWI benchmark. On an absolute basis, the Strategy saw losses across nine of the 10 sectors in which it was invested (out of 11 total) with the consumer discretionary sector the lone contributor while the health care, financials and information technology (IT) sectors were the primary detractors. Try to spare some time to check the fund’s top 5 holdings for you to have an idea about their best stock picks this 2022.

In its Q3 2022 investor letter, ClearBridge Global Growth Strategy mentioned Haleon plc (NYSE:HLN) and explained its insights for the company. Founded in 2022, Haleon plc (NYSE:HLN) is a Weybridge, United Kingdom-based multinational consumer healthcare company with a $29.6 billion market capitalization. Haleon plc (NYSE:HLN) delivered a 7.54% return and it closed at $6.42 per share on November 09, 2022.

Here is what ClearBridge Global Growth Strategy has to say about Haleon plc (NYSE:HLN) in its Q3 2022 investor letter:

“Our recent positioning moves, highlighted by five new additions, reinforce this focus on managing a portfolio of resilient growth companies. Haleon (NYSE:HLN), a U.K.-based consumer health spinout of GlaxoSmithKline, is comprised of a combination of consumer health brands across various over the counter health care categories, oral health as well as vitamins and supplements, with leading share positions in multiple categories. The company generates approximately £10 billion in revenues globally with its flagship brands generating close to 60% of sales at higher-than-average profit margins.”

Africa Studio/Shutterstock.com

Our calculations show that Haleon plc (NYSE:HLN) fell short and didn’t make it on our list of the 30 Most Popular Stocks Among Hedge Funds. Haleon plc (NYSE:HLN) delivered a -1.38% return in the past 3 months. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters 2022 Q3 page.

Suggested Articles:

Disclosure: None. This article is originally published at Insider Monkey.